Todd Alfred Carter - 06 Jan 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Chief Scientific Officer
Signature
/s/ Robert Hesslein, as Attorney-in-Fact for Todd Carter
Issuer symbol
VYGR
Transactions as of
06 Jan 2023
Net transactions value
-$481
Form type
4
Filing time
10 Jan 2023, 15:07:34 UTC
Previous filing
21 Sep 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Award $2,006 +388 +1.1% $5.17 36,582 31 Dec 2022 Direct F1
transaction VYGR Common Stock Sale $2,487 -388 -1.1% $6.41 36,194 06 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).